Current analysis of bloodstream infections in adult intensive care unit patients: a multi-center cohort study of China.
10.3760/cma.j.cn121430-20240923-00791
- Author:
Shuguang YANG
1
;
Yao SUN
1
;
Ting WANG
1
;
Hua ZHANG
2
;
Wei SUN
3
;
Youzhong AN
1
;
Huiying ZHAO
1
Author Information
1. Department of Critical Care Medicine, Peking University People's Hospital, Beijing 100044, China.
2. Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China.
3. Department of Critical Care Medicine, Peking University International Hospital, Beijing 102206, China. Corresponding author: Zhao Huiying, Email: zhaohuiying@pku.edu.cn.
- Publication Type:English Abstract
- MeSH:
Adult;
Humans;
Bacteremia/microbiology*;
China/epidemiology*;
Cohort Studies;
Cross Infection/microbiology*;
Drug Resistance, Bacterial;
Intensive Care Units/statistics & numerical data*;
Prospective Studies;
Risk Factors;
Sepsis/microbiology*
- From:
Chinese Critical Care Medicine
2025;37(3):232-236
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the clinical characteristics, microbiological analysis, and drug resistance patterns of intensive care unit (ICU) bloodstream infection.
METHODS:A prospective cohort study method was employed to collect clinical data from patients suspected of bloodstream infection (BSI) during their stay in ICUs across 67 hospitals in 16 provinces and cities nationwide, from July 1, 2021, to December 31, 2022. Electronic data collection technology was used to gather general information on ICU patients, including gender, age, length of hospital stay, as well as diagnostic results, laboratory tests, imaging studies, microbiological results (including smear, culture results, and pathogen high-throughput testing), and prognosis. Patients were divided into a BSI group and a non-BSI group based on the presence or absence of BSI; further, patients with BSI were categorized into a drug-resistant group and a non-drug-resistant group based on the presence or absence of drug resistance. Differences in the aforementioned indicators between groups were analyzed and compared; variables with P < 0.10 in the univariate analysis were included in a multivariate Logistic regression analysis to identify risk factors for mortality and drug resistance in ICU patients with BSI.
RESULTS:A total of 2 962 ICU patients suspected of BSI participated in the study, including 790 in the BSI group and 2 172 in the non-BSI group. Patients in the BSI group were mainly from East China and Southwest China, with significantly higher age and mortality rates than those in the non-BSI group. Among ICU patients with BSI, Staphylococcus had the highest detection rate (8.10%), followed by Klebsiella pneumoniae (7.47%); there were 169 cases in the drug-resistant group and 621 cases in the non-drug-resistant group; 666 cases survived, and 124 cases died (mortality was 15.70%). There were statistically significant differences between the death group and the survival group in terms of age, regional distribution, and bloodstream infections caused by Gram negative (G-) bacilli, Enterococcus faecium, Aspergillus, and Klebsiella pneumoniae; multivariate Logistic regression analysis showed that age [odds ratio (OR) = 1.01, 95% confidence interval (95%CI) was 1.00-1.03], regional distribution (OR = 4.07, 95%CI was 1.02-1.34), Enterococcus faecium infection (OR = 3.64, 95%CI was 1.16-11.45), and Klebsiella pneumoniae infection (OR = 2.64,95%CI was 1.45-4.80) were independent risk factors for death in ICU patients with BSI (all P < 0.05). There were statistically significant differences between the drug-resistant group and the non-drug-resistant group in terms of age and bloodstream infections caused by Gram positive (G+) cocci and G- bacilli; multivariate Logistic regression analysis showed that age (OR = 1.01,95%CI was 1.00-1.03), G- bacilli infection (OR = 2.18, 95%CI was 1.33-3.59), Escherichia coli infection (OR = 0.28,95%CI was 0.09-0.84), and Enterococcus faecium infection (OR = 3.35, 95%CI was 1.06-10.58) were independent risk factors for drug resistance in ICU patients with BSI (all P < 0.05).
CONCLUSIONS:Bloodstream infections may increase the mortality of ICU patients. Older age, regional distribution, Enterococcus faecium infection and Klebsiella pneumoniae infection can increase the mortality rate of ICU patients with BSI; bloodstream infections caused by G- bacilli are prone to drug resistance, but have no significant impact on the mortality of ICU patients with BSI.
